[Skip navigation]

• About Us
• Support CBCRP
• Donate Online
• Media Center
• Contact Us

 

Home > Research Portfolio > by Title

The Title

0

1

2

3

4

5

6

7

8

9

A

B

C

D

E

F

G

H

I

J

K

L

M

N

O

P

Q

R

S

T

U

V

W

X

Y

Z

Title, Institution	Investigator	Award Cycle	Award

2  Top

2-D Magnetic Resonance Spectroscopy of Breast Tumors			2001 (Cycle VII)	$62,644
	University of California, Los Angeles	Wyckoff ,Nathaniel

3  Top

3rd Symposium on the Intraductal Approach to Breast Cancer			2003 (Cycle IX)	$25,000
	Dr. Susan Love Research Foundation	Love ,M.D., M.B.A. Susan

4  Top

4th Inter. Symp. on the Intraductal Approach to the Breast			2005 (Cycle XI)	$25,000
	Dr. Susan Love Research Foundation	Love ,M.D., M.B.A. Susan

A  Top

A Blueprint for Advancing Quality in Breast Cancer			2005 (Cycle XI)	$24,586
	University of California, San Francisco	Esserman ,M.D. Laura
A Candidate Breast Tumor Suppressor Gene on Chromosome 13			1995 (Cycle I)	$305,953
	California Pacific Medical Center Research Institute	Schott ,Ph.D. David
A Candidate Marker of Mammary Tumor Initiating Cells			2006 (Cycle XII)	$286,500
	The Burnham Institute for Medical Research	Terskikh ,Ph.D. Alexey
A Community-based Workbook for Helping Rural Cancer Patients			1997 (Cycle III)	$58,512
	Stanford University	Koopman ,Ph.D. Cheryl
A Community-Based Workbook for Helping Rural Cancer Patients			1997 (Cycle III)	$46,410
	Sierra Nevada Memorial Hospital Cancer Center	Kreshka ,M.A. Mary Anne
A Network-Based Intervention for Chamorros in Southern CA			2001 (Cycle VII)	$165,419
	University of California, Irvine	Park Tanjasiri ,DrPH, MPH Sora
A Network-Based Intervention for Chamorros in Southern CA			2001 (Cycle VII)	$59,891
	CSU Fullerton Auxiliary Services Corporation	Park Tanjasiri ,DrPH, MPH Sora
A Network-Based Intervention for Chamorros in Southern CA			2001 (Cycle VII)	$376,796
	Guam Communications Network, Inc.	Sablan Santos ,Lola
A New and Practical PET Detector for Imaging Breast Cancer			1996 (Cycle II)	$69,139
	University of California, Los Angeles	Shao ,Ph.D. Yiping
A New Approach to Immune Therapy for Breast Cancer			1996 (Cycle II)	$204,839
	University of California, Los Angeles	Roth ,M.D. Michael
A New Class of Drugs to Treat Breast Cancer			2000 (Cycle VI)	$33,694
	University of California, San Francisco	Robertson ,Ph.D. Thomas
A New Gene Regulation Factor, LMO-4, in Breast Cancer			1999 (Cycle V)	$134,677
	University of California, San Diego	Andersen ,M.D. Bogi
A New Gene Regulation Factor, LMO-4, in Breast Cancer			1999 (Cycle V)	$54,823
	University of California, Irvine	Andersen ,M.D. Bogi
A New Genetic Vaccine Therapy for Breast Cancer			2001 (Cycle VII)	$100,000
	University of California, Irvine	Nelson ,M.D. Edward
A New Marker for Mammary Epithelial Stem Cells?			2006 (Cycle XII)	$188,827
	The Burnham Institute for Medical Research	Oshima ,Ph.D. Robert
A New Model for Inflammatory Breast Carcinoma			1999 (Cycle V)	$200,000
	University of California, Los Angeles	Barsky ,M.D. Sanford
A New Mouse Model of PI3-Kinase Induced Breast Cancer			2007 (Cycle XIII)	$89,600
	University of California, San Francisco	Zhang ,Ph.D. Jun
A New Radiotracer for Sentinel Node Imaging of Breast Cancer			1996 (Cycle II)	$27,183
	University of California, San Diego	Vera ,Ph.D. David
A New Radiotracer for Sentinel Node Imaging of Breast Cancer			1996 (Cycle II)	$105,782
	University of California, Davis	Vera ,Ph.D. David
A New System for Breast Cancer Drug Delivery			1998 (Cycle IV)	$73,185
	California Pacific Medical Center Research Institute	Drummond ,Ph.D. Daryl
A Non-Invasive Method of Locating Malignant Breast Tumors			1995 (Cycle I)	$189,421
	University of California, Los Angeles	Hoffman ,Ph.D. Edward
A Novel Anti-estrogen Resistance Mechanism in Breast Cancer			2002 (Cycle VIII)	$143,250
	The Burnham Institute for Medical Research	Ely ,Ph.D. Kathryn
A Novel Antigen Associated with Breast Cancer Metastasis			2000 (Cycle VI)	$135,132
	Sidney Kimmel Cancer Center	Testa ,Ph.D. Jacqueline
A Novel Approach to Inactivate the Estrogen Receptor			2004 (Cycle X)	$60,000
	University of California, San Francisco	So ,B.A. Alex
A Novel Biological Framework for the Role of Xenoestrogens			2006 (Cycle XII)	$279,242
	California Pacific Medical Center Research Institute	Dairkee ,Ph.D. Shanaz
A Novel Drug Induces Apoptosis in Breast Cancer Cells			1998 (Cycle IV)	$228,595
	Stanford University	Rosen ,M.D. Glenn
A Novel Epithelial-Stromal Model of Metastatic Breast Cancer			2005 (Cycle XI)	$205,716
	Lawrence Berkeley National Laboratory	Neve ,Ph.D. Richard
A Novel Gene Associated With an Altered Risk of Breast Cance			1998 (Cycle IV)	$373,725
	University of California, Berkeley	Nandi ,Ph.D. Satyabrata
A Novel Predictive Test for Her-2/EGFR Ab-based Therapeutics			2003 (Cycle IX)	$79,600
	University of California, San Francisco	Kallab ,M.D. Verena
A Novel Signal Transduction Pathway in Breast Cancer			2000 (Cycle VI)	$79,981
	University of California, San Diego	Cao ,Ph.D., M.D. Yixue
A Patient Decision Support Framework for Breast Cancer			2000 (Cycle VI)	$148,400
	University of California, San Francisco	Hunt ,Ph.D. C. Anthony
A Peptide Vaccine for Breast Cancer Prevention			1995 (Cycle I)	$85,349
	Epimmune Inc.	Sette ,Ph.D. Alessandro
A Peptide Vaccine for Breast Cancer Prevention			1995 (Cycle I)	$304,385
	Cytel Corporation	Sette ,Ph.D. Alessandro
A Role for p53 and Splicing Factor SAP145 in Breast Cancer			2005 (Cycle XI)	$76,000
	University of California, Irvine	Truong ,B.S. Lan
A Role for RAD51B in Breast Cancer			1999 (Cycle V)	$406,092
	Lawrence Livermore National Laboratory	Albala ,Ph.D. Joanna
A Study of the Molecular Heterogeneity of LCIS			2000 (Cycle VI)	$150,000
	University of California, Los Angeles	Barsky ,M.D. Sanford
A Support Group Alternative for Rural and Isolated Women			1999 (Cycle V)	$588,328
	Stanford University	Kreshka ,M.A. Mary Anne
A Support Group Alternative for Rural and Isolated Women			1999 (Cycle V)	$588,328
	Stanford University	Koopman ,Ph.D. Cheryl
A Targeted Therapy for Wound-like Breast Cancers			2006 (Cycle XII)	$232,934
	Stanford University	Chang ,M.D, Ph.D. Howard
A Vascular Restriction of Mammary Tumor Progression			2000 (Cycle VI)	$384,466
	The Burnham Institute for Medical Research	Oshima ,Ph.D. Robert
Abnormal Regulation in Breast Cancer Development/Metastasis			1996 (Cycle II)	$516,413
	Scripps Research Institute	Knaus ,Ph.D. Ulla
Activity Based Profiling of Breast Cancer Xenografts			2003 (Cycle IX)	$30,000
	Scripps Research Institute	Jessani ,B.S. Nadim
ACTR/A1B1 in Mammary Gland Development and Tumorigenesis			1999 (Cycle V)	$16,178
	Salk Institute for Biological Studies	Xie ,M.D., Ph.D. Wen
Addressing Cultural & Tribal Issues in Breast Cancer			2006 (Cycle XII)	$88,625
	Turtle Health Foundation	Navarro ,Linda
Addressing Cultural & Tribal Issues in Breast Cancer			2006 (Cycle XII)	$66,363
	University of California, Davis	von Friederichs-Fitzwater,Ph.D. Marlene
African American Women and Breast Cancer: What Works?			2002 (Cycle VIII)	$131,244
	Kaiser Foundation Research Institute	Banks ,M.A. Priscilla
African American Women and Breast Cancer: What Works?			2002 (Cycle VIII)	$131,244
	Kaiser Foundation Research Institute	Somkin ,Ph.D. Carol
Alcohol Intake & Risk of Estrogen-Receptor Positive Br Ca			1995 (Cycle I)	$73,996
	University of Southern California	Enger ,Ph.D. Shelley
Alteration of Developmental Genes in Breast Cancer			1998 (Cycle IV)	$292,500
	The Burnham Institute for Medical Research	Yamamoto ,Ph.D. Fumiichiro
Alteration of Dietary Fat To Reduce Breast Cancer Metastasis			1995 (Cycle I)	$290,950
	University of California, Davis	Erickson ,Ph.D. Kent
Altering telomerase to prevent breast cancer progression			1996 (Cycle II)	$44,677
	University of California, San Francisco	Blackburn ,Ph.D. Elizabeth
Alternative pre-mRNA Splicing in Mammary Epithelial Cells			2003 (Cycle IX)	$119,968
	Lawrence Berkeley National Laboratory	Conboy ,Ph.D. John
An Approach to Antiestrogen Resistance in Breast Cancer			2005 (Cycle XI)	$134,500
	University of California, San Diego	Tyurina ,Ph.D. Oksana
Analogs of tea polyphenols for breast cancer chemoprevention			1996 (Cycle II)	$429,092
	SRI International	Zaveri ,Ph.D. Nurulain
Analysis of a New Human Caspase in Breast Cancer			2000 (Cycle VI)	$51,527
	The Burnham Institute for Medical Research	Lee ,M.D., Ph.D. Sug Hyung
Analysis of a Protease Involved in Mammary Development			2001 (Cycle VII)	$79,595
	Lawrence Berkeley National Laboratory	Zahedi ,Ph.D. Rana
Analysis of Angiogenic Pathways in Metastatic Breast Cancer			2000 (Cycle VI)	$86,400
	The Burnham Institute for Medical Research	Hindmarsh ,Ph.D. Elizabeth
Analysis of EGFR Transcript Splicing in C. Elegans			2002 (Cycle VIII)	$86,400
	California Institute of Technology	Van Buskirk ,Ph.D. Cheryl
Analysis of Genes Predictive of Breast Cancer Metastasis			2000 (Cycle VI)	$221,925
	University of California, Davis	Gregg ,M.D. Jeffrey
Analysis of MicroRNA Expression in Breast Cancer Stem Cells			2006 (Cycle XII)	$135,000
	Stanford University	Shimono ,M.D., Ph.D. Yohei
Analysis of Rac Mutations in Breast Cancer			1997 (Cycle III)	$87,413
	Scripps Research Institute	Jackson ,M.D. Janis
Androgen Receptor Gene and p21 Gene in Breast Cancer			2005 (Cycle XI)	$34,293
	University of Southern California	Wang ,M.D. Wei
Androgen Receptor Gene and PSA Gene in Breast Cancer Risk			2002 (Cycle VIII)	$59,557
	University of Southern California	Wang ,M.D. Wei
Angiogenesis in Hyperplasia to In-Situ Breast Cancers			2003 (Cycle IX)	$250,000
	University of California, Irvine	Su ,Ph.D. Min-Ying (Lydia)
Antibody Fusion Proteins for the Therapy of Breast Cancer			1997 (Cycle III)	$193,224
	University of California, Los Angeles	Morrison ,Ph.D. Sherie
Antibody-IL-2 Fusion Protein for Breast Cancer Immunotherapy			1998 (Cycle IV)	$419,144
	Sidney Kimmel Cancer Center	Lustgarten ,Ph.D. Joseph
Anti-breast cancer activity of vitamin A derivatives			1996 (Cycle II)	$76,126
	The Burnham Institute for Medical Research	Agadir ,Ph.D. Anissa
Anti-E-Cadherin Apoptosis of Inflammatory Breast Carcinoma			2000 (Cycle VI)	$80,000
	University of California, Los Angeles	Alpaugh ,Ph.D. Mary
Apaf-1 is a Transcriptional Target for the ZNF217 Oncogene			2005 (Cycle XI)	$53,649
	University of California, Davis	Krig ,Ph.D. Sheryl
Apogossypol Derivatives for Breast Cancer Therapy			2004 (Cycle X)	$285,764
	The Burnham Institute for Medical Research	Pellecchia ,Ph.D. Maurizo
Architecture of the ErbB2 Molecule Leading to Breast Cancer			1996 (Cycle II)	$222,349
	University of California, San Francisco	Marks ,Ph.D. Cara
Are EGF-Receptors Activated by IL-8 in Breast Cancer?			2001 (Cycle VII)	$155,475
	La Jolla Institute for Molecular Medicine	Schraufstatter ,M.D. Ingrid
Arginine Deiminase as an Innovative Anti-Breast Cancer Agent			2000 (Cycle VI)	$81,507
	University of Southern California	Shen ,Ph.D. Wei-Chiang
'Art for Recovery': Expanding Access for the Underserved			2003 (Cycle IX)	$83,368
	Stanford University	Collie ,Ph.D. Kate
Artemisinin Disrupts Estrogen Receptor-Alpha and Cell Growth			2006 (Cycle XII)	$100,000
	University of California, Berkeley	Firestone ,Ph.D. Gary
Assessing Recurrent Genomic Aberrations Linked to Ethnicity			2004 (Cycle X)	$100,000
	University of California, San Francisco	Chin ,M.D., Ph.D. Koie
Assessing the Impact of Shame and Guilt in Recovery			2003 (Cycle IX)	$153,535
	Stanford University	Giese-Davis ,Ph.D. Janine
Autoantibodies in Breast Cancer			1997 (Cycle III)	$130,130
	Scripps Research Institute	Ochs ,Ph.D. Robert
Axon Guidance Proteins in Mammary Gland Development			2004 (Cycle X)	$449,228
	University of California, Santa Cruz	Hinck ,Ph.D. Lindsay

B  Top

Bax gene expression in breast cancer			1995 (Cycle I)	$559,057
	The Burnham Institute for Medical Research	Reed ,M.D., Ph.D. John
BCT.org: Feasibility of a Clinical Trial Matching Tool			2003 (Cycle IX)	$99,200
	University of California, San Francisco	Lieberman ,Ph.D. Morton
BCT.org: Feasibility of a Clinical Trial Matching Tool			2003 (Cycle IX)	$99,200
	University of California, San Francisco	Park ,M.D. John
Beliefs and Risks of Breast Cancer Among African Immigrants			1999 (Cycle V)	$236,853
	University of California, San Francisco	Beyene ,Ph.D. Yewoubdar
Benign Breast Disease, Biopsy & Cancer Preventive Self-Care			1995 (Cycle I)	$224,351
	University of California, Davis	O'Connor ,Ph.D. Jacqueline
Biochemical and Functional Characterization of BRCA1			1998 (Cycle IV)	$75,445
	Salk Institute for Biological Studies	Ruffner ,Ph.D. Heinz
Biochemical Correlates for Clinical Response to Paclitaxel			1997 (Cycle III)	$110,390
	University of Southern California	Formenti ,M.D. Silvia
Biologic Determinants of Response to Paclitaxel & Radiation			1998 (Cycle IV)	$595,661
	University of Southern California	Formenti ,M.D. Silvia
Biologic Determinants of Response to Paclitaxel & Radiation			1998 (Cycle IV)	$595,661
	University of Southern California	Danenberg ,Ph.D. Peter
Biologic Determinants of Response to Paclitaxel & Radiation			1998 (Cycle IV)	$595,661
	University of Southern California	Muggia ,M.D. Franco
Biology of Telomere Length Conservation in Breast Cancer			1995 (Cycle I)	$78,798
	University of Southern California	Shibata ,M.D. Darryl
Birth Characteristics and Breast Cancer in Young Women			2004 (Cycle X)	$691,791
	Northern California Cancer Center	Reynolds ,Ph.D. Peggy
Birth Characteristics and Breast Cancer in Young Women			2004 (Cycle X)	$212,553
	Impact Assessment, Inc.	Reynolds ,Ph.D. Peggy
Bispecific Antibodies for Radiotherapy of Breast Cancer			1999 (Cycle V)	$68,615
	University of California, Davis	Winthrop ,Ph.D. Michelle
Blocking Breast Cancer Progression with Radioactive Antibody			1995 (Cycle I)	$50,000
	University of California, Irvine	Samoszuk ,M.D. Michael
Blocking Stromelysin-3 to Inhibit Breast Cancer Metastasis			1997 (Cycle III)	$358,783
	SRI International	Zaveri ,Ph.D. Nurulain
Blood Vessel Markers in Breast Cancer			2001 (Cycle VII)	$378,655
	The Burnham Institute for Medical Research	Ruoslahti ,M.D., Ph.D. Erkki
Bovine leukemia virus and human breast cancer risk			1996 (Cycle II)	$50,000
	University of California, Berkeley	Buehring ,Ph.D. Gertrude
Bovine Leukemia Virus and Human breast Cancer Risk			1997 (Cycle III)	$150,000
	University of California, Berkeley	Buehring ,Ph.D. Gertrude
Bovine Leukemia Virus and Mammary Cell Infection			1997 (Cycle III)	$69,981
	University of California, Berkeley	Kingsbury ,Ph.D. Linda
Bovine Leukemia Virus Infection and Human Breast Cancer Risk			2000 (Cycle VI)	$187,414
	University of California, Berkeley	Buehring ,Ph.D. Gertrude
BRCA1 regulation in breast cancer: a rat mammary model			1996 (Cycle II)	$368,159
	University of Southern California	Williams-Hill ,Ph.D. Donna
BRCA1-dependent Ubiquitin Ligase Activity in Breast Cancer			2002 (Cycle VIII)	$65,297
	Salk Institute for Biological Studies	Xia ,Ph.D. Yan
Breast Cancer and Genetic Differences in Estrogen Formation			1996 (Cycle II)	$81,598
	University of Southern California	Probst-Hensch ,Ph.D. Nicole
Breast Cancer Cell Binding to the Endothelium			1999 (Cycle V)	$326,892
	Scripps Research Institute	Felding-Habermann ,Ph.D. Brunhilde
Breast Cancer Chemoprevention by Retinoids			1997 (Cycle III)	$967,300
	The Burnham Institute for Medical Research	Zhang ,Ph.D. Xiao-Kun
Breast Cancer Chemoprevention by Vitamin D Plus Retinoids			1995 (Cycle I)	$466,049
	SRI International	Dawson ,Ph.D. Marcia
Breast Cancer Chemoprevention with Dietary Herbal Estrogens			2004 (Cycle X)	$199,310
	University of California, San Francisco	Leitman ,M.D., Ph.D. Dale
Breast Cancer Chemotherapy: Does It Impair Brain Function?			1995 (Cycle I)	$307,456
	California School of Professional Psychology	Wieneke ,Ph.D. Mary
Breast Cancer Education for Deaf and Hard-of-Hearing Women			2006 (Cycle XII)	$375,000
	Greater Los Angeles Council on Deafness, Inc.	Kleiger ,B.S. Heidi
Breast Cancer Education for Deaf and Hard-of-Hearing Women			2006 (Cycle XII)	$300,000
	University of California, Los Angeles	Berman ,Ph.D. Barbara
Breast Cancer Functional Imaging with Optics and MRI			2004 (Cycle X)	$500,000
	University of California, Irvine	Butler ,M.D. John
Breast Cancer Functional Imaging with Optics and MRI			2004 (Cycle X)	$500,000
	University of California, Irvine	Hylton ,Ph.D. Nola
Breast Cancer Functional Imaging with Optics and MRI			2004 (Cycle X)	$500,000
	University of California, Irvine	Tromberg ,Ph.D. Bruce
Breast Cancer Gene Expression Using Amplified Core Biopsies			1999 (Cycle V)	$155,286
	Stanford University	Jeffrey ,M.D. Stefanie
Breast Cancer Gene Therapy Using a Metastasis Inhibitor			1997 (Cycle III)	$75,599
	University of Southern California	Zhou ,M.D., Ph.D Qing
Breast Cancer Imaging by 2-D Magnetic Resonance Spectroscopy			2001 (Cycle VII)	$248,762
	University of California, Los Angeles	Thomas ,Ph.D. Michael Albert
Breast Cancer Immunotherapy Using CD4+ Lymphocytes			1998 (Cycle IV)	$43,289
	University of California, San Diego	Mitchell ,M.D. Malcolm
Breast Cancer in California Teachers- Regional Variations			2000 (Cycle VI)	$160,267
	Public Health Institute	Reynolds ,Ph.D. Peggy
Breast Cancer Incidence in California Flight Attendants			1997 (Cycle III)	$56,922
	Public Health Institute	Reynolds ,Ph.D. Peggy
Breast Cancer Incidence in Women with Abnormal Cytology			1995 (Cycle I)	$329,176
	University of California, San Francisco	Wrensch ,M.P.H., Ph.D. Margaret
Breast Cancer Knowledge/Attitudes:So. Cal. Pacific Islanders			1997 (Cycle III)	$70,000
	University of California, Irvine	Park Tanjasiri ,DrPH, MPH Sora
Breast Cancer Lymphedema: Role of Insulin Resistance/FOXC2			2005 (Cycle XI)	$234,178
	Stanford University	Rockson ,M.D. Stanley
Breast Cancer Metastasis: a Heritable Trait?			2006 (Cycle XII)	$264,595
	Stanford University	Whittemore ,Ph.D., M.A. Alice
Breast Cancer Prevention and Control Among Deaf Women			2001 (Cycle VII)	$110,015
	University of California, Los Angeles	Berman ,Ph.D. Barbara
Breast Cancer Prevention and Control Among Deaf Women			2001 (Cycle VII)	$110,015
	University of California, Los Angeles	Kleiger ,B.S. Heidi
Breast Cancer Prevention by Analogs of EGCG from Green Tea			2000 (Cycle VI)	$296,115
	SRI International	Zaveri ,Ph.D. Nurulain
Breast Cancer Prevention by Inhibition of Estrogen Action			1999 (Cycle V)	$302,983
	Cedars-Sinai Medical Center	Davis ,Ph.D. Vicki
Breast Cancer Prevention with Estrogen			2002 (Cycle VIII)	$812,340
	University of California, Berkeley	Nandi ,Ph.D. Satyabrata
Breast Cancer Prevention with Phytochemicals in Mushrooms			2004 (Cycle X)	$759,667
	Beckman Research Institute of the City of Hope	Chen ,Ph.D. Shiuan
Breast Cancer Prevention with Phytoestrogens in Grape Juice			1998 (Cycle IV)	$539,331
	Beckman Research Institute of the City of Hope	Chen ,Ph.D. Shiuan
Breast Cancer Prevention: The Views of Women and Physicians			2000 (Cycle VI)	$434,559
	University of California, San Francisco	Kaplan ,DrPH Celia
Breast Cancer Progression and the Extracellular Matrix			1995 (Cycle I)	$493,643
	University of Southern California	Markland ,Ph.D. Francis
Breast Cancer Risk Associated with High Mammographic Density			2005 (Cycle XI)	$148,163
	University of California, San Francisco	Tlsty ,Ph.D. Thea
Breast Cancer Risk Factors and Hormone Receptors			1996 (Cycle II)	$271,408
	Kaiser Foundation Research Institute	Geiger ,M.P.H., Ph.D. Ann
Breast Cancer Risk Factors: Lesbian & Heterosexual Women			1997 (Cycle III)	$31,943
	University of California, San Francisco	Dibble ,D.N.Sc., RN Suzanne
Breast Cancer Risk Factors: Lesbian & Heterosexual Women			1997 (Cycle III)	$23,991
	Lyon-Martin Women's Health Services	Roberts ,M.D. Stephanie
Breast Cancer Risk Factors: Lesbian and Heterosexual Women			1998 (Cycle IV)	$169,423
	Lyon-Martin Women's Health Services	Roberts ,M.D. Stephanie
Breast Cancer Risk Factors: Lesbian and Heterosexual Women			1998 (Cycle IV)	$186,214
	University of California, San Francisco	Dibble ,D.N.Sc., RN Suzanne
Breast Cancer Risk Profile of Vietnamese Nail Salon Workers			2005 (Cycle XI)	$67,322
	Asian Health Services	Nguyen ,Kim
Breast Cancer Risk Profile of Vietnamese Nail Salon Workers			2005 (Cycle XI)	$7,393
	Impact Assessment, Inc.	Reynolds ,Ph.D. Peggy
Breast Cancer Risk Profile of Vietnamese Nail Salon Workers			2005 (Cycle XI)	$44,798
	Northern California Cancer Center	Reynolds ,Ph.D. Peggy
Breast Cancer Risks in California Nail Salon Workers			2007 (Cycle XIII)	$349,303
	Northern California Cancer Center	Reynolds ,Ph.D. Peggy
Breast Cancer Risks in California Nail Salon Workers			2007 (Cycle XIII)	$317,610
	Asian Health Services	Okahara ,Linda
Breast Cancer Screening in Women Surviving Hodgkin's Disease			1999 (Cycle V)	$1,033,898
	Stanford University	Hancock ,M.D. Steven
Breast Cancer Studies in a 3-D Cell Culture System			2005 (Cycle XI)	$188,602
	The Burnham Institute for Medical Research	Vuori ,M.D., Ph.D. Kristiina
Breast Cancer Survivorship: Partner's Role in Recovery			1999 (Cycle V)	$610,760
	University of Southern California	Meyerowitz ,Ph.D. Beth
Breast Cancer Susceptibility Genes in Very High Risk Women			1999 (Cycle V)	$129,247
	University of Southern California	Hamilton ,Ph.D. Ann
Breast Cancer Treatment Monitoring Combining MRI and Optics			2007 (Cycle XIII)	$149,527
	University of California, San Francisco	Klifa ,Ph.D. Catherine
Breast Carcinoma Associated MAR-binding Proteins p90 and p70			1997 (Cycle III)	$69,998
	Lawrence Berkeley National Laboratory	Galande ,Ph.D. Sanjeev
Breast CT for Much Earlier Detection of Breast Cancer			2001 (Cycle VII)	$500,000
	University of California, Davis	Boone ,Ph.D. John
Breast CT for Much Earlier Detection of Breast Cancer			2001 (Cycle VII)	$500,000
	University of California, Davis	Lindfors ,M.D. Karen
Breast Health Behaviors of Immigrant Afghan Women			2007 (Cycle XIII)	$70,481
	University of California, Berkeley	Bloom ,Ph.D. Joan
Breast Health Behaviors of Immigrant Afghan Women			2007 (Cycle XIII)	$99,255
	Afghan Coalition	Shirazi ,Aida
Breast Health Literacy and Health Care Decision Making			2006 (Cycle XII)	$6,000
	Operation Samahan Inc.	San Juan ,M.S. Joel
Breast Health Literacy and Health Care Decision Making			2006 (Cycle XII)	$3,964
	San Diego State University Research Foundation	Lindsay ,Ph.D., MSW, MPH Suzanne
Breast Health Project for Hmong Women and Men			1999 (Cycle V)	$496,322
	University of California, Los Angeles	Foo ,M.P.H., CHES Mary Anne
Breast Health Project for Hmong Women and Men			1999 (Cycle V)	$496,322
	University of California, Los Angeles	Kagawa-Singer ,Ph.D., R.N., M.N., M.A. Marjorie
Breast Screening Program in the Hmong American Community			1997 (Cycle III)	$74,250
	University of California, Los Angeles	Kagawa-Singer ,Ph.D., R.N., M.N., M.A. Marjorie
Breast Stromal Genes Act as Early Markers of Malignancy			2002 (Cycle VIII)	$398,072
	Stanford University	Tlsty ,Ph.D. Thea
Breast Stromal Genes Act as Early Markers of Malignancy			2002 (Cycle VIII)	$249,624
	University of California, San Francisco	Tlsty ,Ph.D. Thea
Breast Stromal Genes Act as Early Markers of Malignancy			2002 (Cycle VIII)	$398,072
	Stanford University	Jeffrey ,M.D. Stefanie
Breast Stromal Genes Act as Early Markers of Malignancy			2002 (Cycle VIII)	$249,624
	University of California, San Francisco	Jeffrey ,M.D. Stefanie
Breast Tumor Inhibition by Vitamin D in a Mouse Model			2006 (Cycle XII)	$234,388
	Stanford University	Feldman ,M.D. David
Breast Tumor Markers and Response to Adjuvant Therapy			1998 (Cycle IV)	$77,327
	Kaiser Foundation Research Institute	Enger ,Ph.D. Shelley
Breast Tumor Responses to Novel TGF-beta Inhibitors			2007 (Cycle XIII)	$90,000
	University of California, San Francisco	Harradine ,Ph.D. Kelly

C  Top

cAMP Antagonists of Protein Kinase as Breast Cancer Drugs			2005 (Cycle XI)	$48,253
	Scripps Research Institute	Saldanha ,Ph.D. Sanjay Adrian
cAMP Antagonists of Protein Kinase as Breast Cancer Drugs			2005 (Cycle XI)	$28,404
	University of California, San Diego	Saldanha ,Ph.D. Sanjay Adrian
Can Molecular Markers Predict Response to Adjuvant Therapy			1999 (Cycle V)	$260,545
	Kaiser Foundation Research Institute	Enger ,Ph.D. Shelley
Can Molecular Markers Predict Response to Adjuvant Therapy?			1999 (Cycle V)	$508,813
	University of Southern California	Press ,M.D., Ph.D. Michael
Can Placenta Factors Explain Race Patterns of Breast Cancer?			2002 (Cycle VIII)	$84,502
	Public Health Institute	Cohn ,Ph.D., MPH, MCP Barbara
Cancer and Complexity: Questions for a New Millenium			2000 (Cycle VI)	$11,760
	Lawrence Berkeley National Laboratory	Barcellos-Hoff ,Ph.D. Mary Helen
Cancer and Complexity: Questions for a New Millenium			2000 (Cycle VI)	$11,760
	Lawrence Berkeley National Laboratory	Bissell ,Ph.D. Mina
Cancer and Complexity: Questions for a New Millenium			2000 (Cycle VI)	$11,760
	Lawrence Berkeley National Laboratory	Harris ,Ph.D. G. Shyamala
Case-Control Study of Breast Cancer in Asian-American Women			1995 (Cycle I)	$639,651
	University of Southern California	Wu ,Ph.D. Anna
Caspase-mediated Apoptosis Mechanisms in Breast Cancer Cells			2002 (Cycle VIII)	$60,000
	The Burnham Institute for Medical Research	Boatright ,B.S. Kelly
Cell Adhesion and Drug Resistance in Breast Cancer			2000 (Cycle VI)	$190,773
	The Burnham Institute for Medical Research	Vuori ,M.D., Ph.D. Kristiina
Cell Adhesion Signaling Defects in Breast Cancer			1998 (Cycle IV)	$26,841
	The Burnham Institute for Medical Research	Zeh ,Ph.D. Karin
Cell Growth Control of Breast Epithelial Cells			2000 (Cycle VI)	$265,950
	Scripps Research Institute	Knaus ,Ph.D. Ulla
Cell Microenvironment and Progression of Breast Cancer			1995 (Cycle I)	$66,048
	Lawrence Berkeley National Laboratory	Lochter ,Ph.D. Andre
Cell-Based Immunotherapy for Breast Cancer			2000 (Cycle VI)	$120,811
	University of California, San Francisco	Jabrane-Ferrat ,Ph.D. Nabila
Cell-Killing Effect of Orphan Receptor TR3 in Breast Cancer			2002 (Cycle VIII)	$84,643
	The Burnham Institute for Medical Research	Bruey-Sedano ,Ph.D. Nathalie
Changes in Transport into the Nucleus in Breast Cancer			1995 (Cycle I)	$5,047
	Scripps Research Institute	Sweet ,Ph.D. Deborah
Characterization of hAG-2 and Its Role in Breast Cancer			1999 (Cycle V)	$166,465
	Stanford University	Thompson ,M.Sc., Ph.D. Devon
Characterization of Heregulin Targeted Genes			1997 (Cycle III)	$22,115
	Lawrence Berkeley National Laboratory	Guerra-Vladusic ,Ph.D. Fabiana
Characterizing Breast Cancer Cells in Blood and Bone Marrow			2004 (Cycle X)	$155,781
	Stanford University	Carlson ,M.D. Robert
Chemical Inhibitors of Hsp70 for Breast Cancer			2006 (Cycle XII)	$135,000
	The Burnham Institute for Medical Research	Shiau ,Ph.D. Chung-Wai
Chemotherapy-Induced Ovarian Damage: Prevention and Impact			2002 (Cycle VIII)	$82,027
	Stanford University	Westphal ,M.D. Lynn
Chemotherapy-Induced Ovarian Damage: Prevention and Impact			2002 (Cycle VIII)	$64,189
	University of California, San Francisco	Berlin ,M.S. Lucy
Chemotherapy-Induced Ovarian Damage: Prevention and Impact			2002 (Cycle VIII)	$64,189
	University of California, San Francisco	Rugo ,M.D. Hope
Child's Stress During Mother's Treatment for Breast Cancer			2001 (Cycle VII)	$127,553
	California Pacific Medical Center Research Institute	Levine ,Ph.D., M.P.H. Ellen
Child's Stress During Mother's Treatment for Breast Cancer			2001 (Cycle VII)	$127,553
	California Pacific Medical Center Research Institute	Ducker ,Ph.D. Dalia
Chinese Herb/Chemotherapy Interactions in Breast Cancer			2003 (Cycle IX)	$200,000
	University of California, San Francisco	Campbell ,Ph.D. Michael
Chinese Herbal Therapy (CHT) for Symptom Management			2000 (Cycle VI)	$200,000
	University of California, San Francisco	Rugo ,M.D. Hope
Chromatin Regulation of Breast Cancer Cell Senescence			1998 (Cycle IV)	$231,844
	Lawrence Berkeley National Laboratory	Kaufman ,Ph.D. Paul
Circuit Training to Lower Breast Cancer Risk in Latina Teens			2007 (Cycle XIII)	$244,500
	University of Southern California	Davis ,Ph.D. Jaimie
Clinical Utility of Breast Cancer DNA Markers in Plasma			1999 (Cycle V)	$372,242
	John Wayne Cancer Institute	Hoon ,MSc, Ph.D. David
Clinical Utility of Breast Cancer DNA Markers in Serum			2001 (Cycle VII)	$470,520
	John Wayne Cancer Institute	Hoon ,MSc, Ph.D. David
Cloning of Senescence Genes in Mammary Epithelial Cells			1999 (Cycle V)	$75,034
	Stanford University	Zhang ,Ph.D. Hong
Cloning of the X Chromosome's Putative Tumor Suppressor Gene			2002 (Cycle VIII)	$284,375
	The Burnham Institute for Medical Research	Malkhosyan ,Ph.D. Sergei
Clotting Breast Cancer